Sedation or Anesthesia Before Cervical Cancer Brachytherapy

Interventions in Gynaecology and Women’s Healthcare Pub Date : 2018-09-27 DOI:10.32474/IGWHC.2018.02.000146

A. Pellizzon

{"title":"Sedation or Anesthesia Before Cervical Cancer Brachytherapy","authors":"A. Pellizzon","doi":"10.32474/IGWHC.2018.02.000146","DOIUrl":null,"url":null,"abstract":"Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still a public health problem in most developing countries. There are no significant differences between the use of high dose rate (HDR-BT) and low dose rate (LDR-BT) brachytherapy when considering overall, disease specific and recurrence free survivals. Cervical dilatation is mandatory for the insertion of intrauterine tandems in any of the techniques cited above. Pain and discomfort may eventually be limiting factors of the outpatient procedure and may lead to unsatisfactory results in terms of adequate position of the applicator set. We reviewed the current sedation and anesthetic options for comfort and safety procedures when performing HDR-BT. Int Gyn & Women’s Health Copyrights@ Antonio Cassio Assis Pellizzon. Citation: Antonio C A P. Sedation or Anesthesia Before Cervical Cancer Brachytherapy. Int Gyn & Women’s Health 2(5)2018. IGWHC. MS.ID.000146. DOI: 10.32474/IGWHC.2018.02.000146. 197 are suitable for inpatients. In Brazil and probably worldwide, besides US and Europe, it is underused due to the shortage of anesthesiologists.","PeriodicalId":220356,"journal":{"name":"Interventions in Gynaecology and Women’s Healthcare","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventions in Gynaecology and Women’s Healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32474/IGWHC.2018.02.000146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still a public health problem in most developing countries. There are no significant differences between the use of high dose rate (HDR-BT) and low dose rate (LDR-BT) brachytherapy when considering overall, disease specific and recurrence free survivals. Cervical dilatation is mandatory for the insertion of intrauterine tandems in any of the techniques cited above. Pain and discomfort may eventually be limiting factors of the outpatient procedure and may lead to unsatisfactory results in terms of adequate position of the applicator set. We reviewed the current sedation and anesthetic options for comfort and safety procedures when performing HDR-BT. Int Gyn & Women’s Health Copyrights@ Antonio Cassio Assis Pellizzon. Citation: Antonio C A P. Sedation or Anesthesia Before Cervical Cancer Brachytherapy. Int Gyn & Women’s Health 2(5)2018. IGWHC. MS.ID.000146. DOI: 10.32474/IGWHC.2018.02.000146. 197 are suitable for inpatients. In Brazil and probably worldwide, besides US and Europe, it is underused due to the shortage of anesthesiologists.

查看原文本刊更多论文

宫颈癌近距离放疗前的镇静或麻醉

宫颈癌是一种具有巨大预防潜力的肿瘤，但在大多数发展中国家仍是一个公共卫生问题。在考虑总体、疾病特异性和无复发生存率时，高剂量率(HDR-BT)和低剂量率(LDR-BT)近距离放疗的使用没有显著差异。在上述任何一种技术中，宫颈扩张都是宫内串联插入的必要条件。疼痛和不适可能最终成为门诊手术的限制因素，并可能导致在适当位置的涂抹器设置方面不满意的结果。我们回顾了当前的镇静和麻醉选择，以确保HDR-BT手术的舒适性和安全性。版权所有@ Antonio Cassio Assis Pellizzon引用本文:Antonio C A P.宫颈癌近距离放疗前的镇静或麻醉。《妇科与妇女健康》2(5)2018。IGWHC。MS.ID.000146。DOI: 10.32474 / IGWHC.2018.02.000146。197个适用于住院病人。除了美国和欧洲，在巴西，也许在世界范围内，由于麻醉师的短缺，它没有得到充分利用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Interventions in Gynaecology and Women’s Healthcare

自引率

0.00%

发文量